KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Treasury Shares: 2019-2024

Historic Treasury Shares for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to $3.3 million.

  • Ginkgo Bioworks Holdings' Treasury Shares rose 14.12% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 14.12%. This contributed to the annual value of $3.3 million for FY2024, which is 12.55% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Treasury Shares of $3.3 million as of FY2024, which was down 12.55% from $3.8 million recorded in FY2023.
  • Ginkgo Bioworks Holdings' 5-year Treasury Shares high stood at $168.3 million for FY2021, and its period low was $3.3 million during FY2024.
  • Its 3-year average for Treasury Shares is $47.2 million, with a median of $3.8 million in 2023.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 25,354.55% in 2020, then tumbled by 97.17% in 2023.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Treasury Shares stood at $124.9 million in 2020, then skyrocketed by 34.73% to $168.3 million in 2021, then declined by 20.13% to $134.4 million in 2022, then crashed by 97.17% to $3.8 million in 2023, then decreased by 12.55% to $3.3 million in 2024.